Targeting serotonin synthesis to treat irritable bowel syndrome

Gastroenterology

Volumn 141, Issue 2, 2011, Pages 420-422

  Tack, Jan ^a   Janssen, Pieter ^a   Wouters, Mira ^a   Boeckxstaens, Guy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LX 1031; OXYGENASE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENTEROCHROMAFFIN CELL; GASTROINTESTINAL SECRETION; INTESTINE MOTILITY; IRRITABLE COLON; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; TREATMENT RESPONSE;

EID: 80051480994     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.024     Document Type: Editorial

References (16)

1. M.D. Gershon, and J. Tack The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132 2007 397 414 (Pubitemid 46127672)
2. B. Geeraerts, O.L. Van, W. Boesmans, and R. Vos Influence of acute tryptophan depletion on gastric sensorimotor function in humans Am J Physiol Gastrointest Liver Physiol 300 2011 G228 G235
3. J. Tack, D. Broekaert, and M. Corsetti Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man Aliment Pharmacol Ther 23 2006 265 274 (Pubitemid 43382036)
4. P. Janssen, L. Van Oudenhove, and C. Casteels The effects of acute citalopram dosing on gastric motor function and nutrient tolerance in healthy volunteers Aliment Pharmacol Ther 33 2011 395 402
5. M.D. Coates, C.R. Mahoney, and D.R. Linden Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome Gastroenterology 126 2004 1657 1664 (Pubitemid 38736329)
6. M. Camilleri, C.N. Andrews, and A.E. Bharucha Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome Gastroenterology 132 2007 17 25 (Pubitemid 46108754)
7. C.P. Bearcroft, D. Perrett, and M.J. Farthing Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study Gut 42 1998 42 46 (Pubitemid 28228386)
8. S.P. Dunlop, N.S. Coleman, and E. Blackshaw Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome Clin Gastroenterol Hepatol 3 2005 349 357 (Pubitemid 40488343)
9. W. Atkinson, S. Lockhart, and P.J. Whorwell Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome Gastroenterology 130 2006 34 43 (Pubitemid 43049833)
10. Q. Liu, Q. Yang, and W. Sun Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract J Pharmacol Exp Ther 325 2008 47 55 (Pubitemid 351439163)
11. M. Camilleri LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin Neurogastroenterol Motil 23 2011 193 200
12. P. Brown, J. Jackson, and Z.-C. Shi LX1031: a new approach for managing irritable bowel syndrome Gastroenterology 136 Suppl 1 2009 A237 (abstract)
13. P.M. Brown, D.A. Drossman, and A.J.J. Wood The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome Gastroenterology 141 2011 507 516
14. M. Thumshirn, B. Coulie, and M. Camilleri Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome Aliment Pharmacol Ther 14 2000 869 878 (Pubitemid 30446897)
15. A.E. Bharucha, M. Camilleri, and S. Haydock Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans Gut 47 2000 667 674
16. S. Kindt, and J. Tack Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders Neurogastroenterol Motil 19 Suppl 2 2007 32 39 (Pubitemid 47037964)